[Form 4] Cryoport, Inc. Insider Trading Activity

Cryoport, Inc. President and CEO Jerrell Shelton exercised stock options to acquire 104,007 shares of common stock at $1.87 per share.

Rhea-AI Filing Summary

Cryoport, Inc. President and CEO Jerrell Shelton exercised stock options to acquire 104,007 shares of common stock at $1.87 per share. These options, which vested monthly over four years beginning May 6, 2016, were fully exercised, leaving 0 options from this grant. After the transaction, Shelton directly holds 1,230,614 common shares, indicating an exercise-and-hold pattern with no same-day share sales reported.

Insider Trade Summary

104,007 shares exercised/converted

Exercise 2 txns

Insider SHELTON JERRELL

Role President, CEO

Type	Security	Shares	Price	Value
Exercise	Options to purchase common stock	104,007	$0.00	$0.00
Exercise	Common Stock	104,007	$1.87	$194K

Holdings After Transaction: Options to purchase common stock — 0 contracts (Direct); Common Stock — 1,230,614 shares (Direct)

Footnotes (1)

1. F1. 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

Key Figures

Options exercised: 104,007 shares Exercise price: $1.87 per share Shares held after: 1,230,614 shares +2 more

5 metrics

Options exercised 104,007 shares Common stock acquired via option exercise

Exercise price $1.87 per share Strike price for exercised options

Shares held after 1,230,614 shares Direct common stock ownership post-transaction

Options remaining from grant 0 options This award after full exercise

Option expiration date May 6, 2026 Original option award expiration

Key Terms

derivative security, Options to purchase common stock, vesting, exercise price

4 terms

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Options to purchase common stock financial

"security_title: Options to purchase common stock"

vesting financial

"1/48 of options vested on the 6th of each month for forty-eight months"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: 1.8700"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cryoport (CYRX) report for CEO Jerrell Shelton?

Cryoport reported that CEO Jerrell Shelton exercised stock options to acquire 104,007 shares of common stock. The options were exercised at $1.87 per share, increasing his direct holdings to 1,230,614 shares with no reported same-day share sales.

Did Cryoport (CYRX) CEO Jerrell Shelton sell any shares in this Form 4 filing?

The Form 4 shows no sales by CEO Jerrell Shelton. He exercised options coded as an “M” transaction, converting 104,007 option units into common stock and retaining the resulting shares, with his direct common stock ownership rising to 1,230,614 shares after the transaction.

At what price were the Cryoport (CYRX) options exercised in this Form 4?

The options were exercised at a price of $1.87 per share. This exercise converted 104,007 options into the same number of Cryoport common shares, reflecting the option’s stated exercise price rather than a market purchase in the open market.

How many Cryoport (CYRX) shares does CEO Jerrell Shelton own after this transaction?

After exercising options, CEO Jerrell Shelton directly holds 1,230,614 shares of Cryoport common stock. This total reflects the addition of 104,007 shares from the option exercise and shows his position size following the reported Form 4 transactions.

What happened to the Cryoport (CYRX) options reported in this Form 4?

The options to purchase 104,007 Cryoport shares were fully exercised, reducing the reported option position to zero. These options vested in 1/48 increments monthly starting May 6, 2016, and were exercised before their May 6, 2026 expiration date.

How many options did Cryoport (CYRX) CEO Jerrell Shelton exercise in this filing?

CEO Jerrell Shelton exercised options on 104,007 shares of Cryoport common stock. This single derivative exercise converted his entire reported option amount from that grant into common shares, with no remaining options from this specific award after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/23/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHELTON JERRELL

(Last) (First) (Middle)

C/O CRYOPORT INC.

112 WESTWOOD PLACE, SUITE 350

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/21/2026		M		104,007	A	$1.87	1,230,614	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock	$1.87	04/21/2026		M			104,007	(1)	05/06/2026	Common Stock	104,007	$0	0	D

Explanation of Responses:

1. 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

	/s/ Jerrell Shelton	04/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)